FDA Considers Ending Pfizer COVID Vaccine Authorization for Children Under 5
TL;DR Summary
The FDA is considering discontinuing emergency use authorization for Pfizer's COVID-19 vaccine for children under 5, potentially leaving healthy children in that age group without officially sanctioned vaccination options this fall, despite ongoing risks and the availability of vaccines for older children and at-risk groups.
- Why Young Children May Not Get Covid Shots This Fall The New York Times
- Pfizer Covid vaccine for young children may not be renewed by FDA The Guardian
- FDA may pull authorization of Pfizer’s Covid vaccine for children under 5 CNBC
- FDA may not renew Pfizer's COVID shot authorization in kids Fierce Pharma
- FDA Weighs Pulling Pfizer’s Covid Vaccine for Kids Under Age 5 Bloomberg.com
Reading Insights
Total Reads
1
Unique Readers
10
Time Saved
5 min
vs 6 min read
Condensed
96%
1,030 → 45 words
Want the full story? Read the original article
Read on The New York Times